← Research library

Thymopentin stability in isolated human plasma

Lab research · 1979

What was studied
Isolated human plasma and a saline control.
Main finding
Apparent half-life in plasma · Approximately 30 seconds in isolated plasma. The investigators observed no comparable degradation in the saline control.

Reported findings and study design

Reported findings

Tritiated thymopentin was incubated in plasma and saline. Thin-layer chromatography and radiolabel measurements tracked the parent peptide and four tyrosine-containing breakdown products.

Population or model Isolated human plasma and a saline control.

Dose, route and schedule

Tritiated thymopentin was incubated in plasma and saline. Thin-layer chromatography and radiolabel measurements tracked the parent peptide and four tyrosine-containing breakdown products.

Protocol source ↗ · Original indexed abstract.

Results · Original indexed abstract.
MeasureResultComparison, timing and statistics
Apparent half-life in plasmaApproximately 30 seconds in isolated plasma. The investigators observed no comparable degradation in the saline control.

This laboratory assay did not measure half-life after administration to people.

Source for these results ↗ · Reviewed 2026-11-14

Study limitations and source details

Study limitations

  • This laboratory assay did not measure half-life after administration to people.

Source details

Original indexed abstract.

Sources checked

Added to the library

Citation

In vitroEnglish abstract

J. P. Tischio, J. E. Patrick, H. S. Weintraub, M. Chasin, G. Goldstein. Thymopentin stability in isolated human plasma International Journal of Peptide and Protein Research 14(5), 479–484

Study source ↗ · DOI 10.1111/j.1399-3011.1979.tb01959.x · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards